We could not find any results for:
Make sure your spelling is correct or try broadening your search.
IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceuti... IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. Show more
Revenue of $3,814 million GAAP Net Income of $363 million, Adjusted EBITDA of $887 million GAAP Diluted Earnings per Share of $1.97, Adjusted Diluted Earnings per Share of $2.64 R&D...
US index futures advanced in pre-market trading on Monday, driven by investor attention to the US political landscape and Verizon’s quarterly results. At 4:56 AM, Dow Jones futures rose 60...
IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a...
IQVIA™ (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions, and clinical research services to the life sciences industry, today announced that the IQVIA SmartSolve...
Bold initiative to boost the capacity of research sites enters Beta testing and piloting IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as...
Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a potential increase of more than 12 million new...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.52 | 0.232091051105 | 224.05 | 237.4105 | 222.005 | 1061942 | 228.05118126 | CS |
4 | 6.36 | 2.91462352779 | 218.21 | 237.4105 | 205.06 | 1380139 | 215.37849325 | CS |
12 | -11.98 | -5.06446839992 | 236.55 | 237.82 | 205.06 | 1198463 | 219.95675687 | CS |
26 | 8.2 | 3.78980450155 | 216.37 | 261.73 | 205.06 | 1064739 | 228.18303683 | CS |
52 | -3.36 | -1.47413679638 | 227.93 | 261.73 | 167.42 | 1102121 | 217.69545653 | CS |
156 | -19.59 | -8.02342726081 | 244.16 | 285.61 | 165.75 | 1027049 | 219.95692222 | CS |
260 | 68.49 | 43.8813429011 | 156.08 | 285.61 | 81.79 | 1105375 | 193.57524003 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions